These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 19328963

  • 21. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH, Ozdem S, Caglar S, Tuncer M, Gurkan A, Yucetin L, Senol Y, Demirbas A, Gultekin M, Ersoy FF, Akaydin M.
    Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
    [Abstract] [Full Text] [Related]

  • 22. Cyclosporine C2 monitoring is superior to C0 in predicting acute cellular rejection in heart transplant recipients in Taiwan.
    Chou NK, Chen RJ, Ko WJ, Lin HL, Yu SY, Chen YS, Hsu RB, Lee CM, Lin FY, Wang SS.
    Transplant Proc; 2004 Oct; 36(8):2393-5. PubMed ID: 15561260
    [Abstract] [Full Text] [Related]

  • 23. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
    Loichot C, Bentue-Ferrer D, Bernard N, Bonardet A, Boulieu R, Kergueris MF, Paintaud G, Peytavin G, Simon N, Marquet P, Therapeutic Drug Monitoring Group of the French Pharmacological Society.
    Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
    [Abstract] [Full Text] [Related]

  • 24. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 25. Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases.
    Büchler M, Chadban S, Cole E, Midtvedt K, Thervet E, Prestele H, Keown P.
    Nephrol Dial Transplant; 2006 Jan; 21(1):197-202. PubMed ID: 16204301
    [Abstract] [Full Text] [Related]

  • 26. Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients: not simply overestimation.
    Cattaneo D, Zenoni S, Murgia S, Merlini S, Baldelli S, Perico N, Gotti E, Ottomano C, Crippa A, Remuzzi G.
    Clin Chim Acta; 2005 May; 355(1-2):153-64. PubMed ID: 15820490
    [Abstract] [Full Text] [Related]

  • 27. Effect of the hematocrit and its correction on the relationship between blood tacrolimus concentrations obtained using the microparticle enzyme immunoassay (MEIA) and enzyme multiplied immunoassay technique (EMIT).
    Bouzas L, Ortega FJ, Casado P, Arranz MI, Carcas A, Tutor JC.
    Clin Lab; 2007 May; 53(9-12):591-6. PubMed ID: 18257466
    [Abstract] [Full Text] [Related]

  • 28. Assessment of cyclosporine pharmacokinetic parameters to facilitate conversion from C0 to C2 monitoring in heart transplant recipients.
    Davies RA, Veinot JP, Williams K, Haddad H, Baker A, Donaldson J, Pugliese C, Struthers C, Masters RG, Hendry PJ, Mesana T.
    Transplant Proc; 2007 Dec; 39(10):3334-9. PubMed ID: 18089382
    [Abstract] [Full Text] [Related]

  • 29. Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment.
    Moscato D, Nonnato A, Adamo R, Vancheri M, Caropreso A.
    Clin Chim Acta; 2010 Jan; 411(1-2):77-80. PubMed ID: 19835852
    [Abstract] [Full Text] [Related]

  • 30. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, de Hemptinne B, Moench C.
    Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
    [Abstract] [Full Text] [Related]

  • 31. [The EMIT Tacrolimus assay: development of application protocol for Roche Hitachi 902 analyzer].
    Yargui L, Berhoune A.
    Ann Biol Clin (Paris); 2008 Nov; 66(6):657-64. PubMed ID: 19091665
    [Abstract] [Full Text] [Related]

  • 32. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M, Di Stasio E, Basile MR, Elisei F, Antonini M, Ettorre GM, Iappelli M, Pucillo LP.
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [Abstract] [Full Text] [Related]

  • 33. Clinically unexpected cyclosporine levels using the ACMIA method on the RXL dimension analyser.
    Morelle J, Wallemacq P, Van Caeneghem O, Goffin E.
    Nephrol Dial Transplant; 2011 Apr; 26(4):1428-31. PubMed ID: 21335442
    [Abstract] [Full Text] [Related]

  • 34. A survey to determine the blood concentration of cyclosporine 2 hours postdose in stable renal transplant patients.
    Jorga A, Holt DW, Yaqoob M, Whittaker C, Johnston A.
    Transplant Proc; 2004 Dec; 36(10):3239-41. PubMed ID: 15686737
    [Abstract] [Full Text] [Related]

  • 35. Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients.
    Takatsuki M, Chen CL, Chen YS, Wang CC, Lin CC, Yang CH, Yong CC, Liu YW.
    Clin Transplant; 2004 Dec; 18(6):694-9. PubMed ID: 15516246
    [Abstract] [Full Text] [Related]

  • 36. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA, Dijkers EC, Uges DR.
    Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
    [Abstract] [Full Text] [Related]

  • 37. Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus.
    Mardigyan V, Giannetti N, Cecere R, Besner JG, Cantarovich M.
    J Heart Lung Transplant; 2005 Oct; 24(10):1614-8. PubMed ID: 16210138
    [Abstract] [Full Text] [Related]

  • 38. C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
    Midtvedt K, Fauchald P, Bergan S, Høieggen A, Hallan S, Svarstad E, Bergrem H, Eriksen BO, Pfeffer PF, Dalen I, Leivestad T.
    Transplantation; 2003 Oct 27; 76(8):1236-8. PubMed ID: 14578761
    [Abstract] [Full Text] [Related]

  • 39. Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: a comparison with cyclosporine neoral.
    Wang CH, Ko WJ, Chou NK, Wang SS.
    Transplant Proc; 2004 Oct 27; 36(8):2386-7. PubMed ID: 15561257
    [Abstract] [Full Text] [Related]

  • 40. Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Hübler M, Abd El Rahman MY, Miera O, Ewert P, Weng Y, Wei H, Krüdewagen B, Hetzer R, Berger F.
    J Heart Lung Transplant; 2006 Jun 27; 25(6):619-25. PubMed ID: 16730566
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.